Acquisition / mergerFiled on BSE ·
Jagsonpal Pharmaceuticals acquires Wellness Portfolio of Group Pharmaceuticals Ltd on Oct 1, 2026
Jagsonpal Pharma · Pharmaceuticals & Biotechnology
What the filing says
- Acquisition completed on October 1, 2026, following fulfillment of conditions precedent
- Consideration includes ₹23.7 Cr upfront and ₹23.0 Cr additional payments linked to FY28 sales
- Wellness portfolio adds 2 key brands, 6 SKUs, and presence across 6 Indian states with ~30,000 doctors covered
Original filing
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies
Electrical Equipment
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Jagsonpal Pharma
- Acquisition / mergerJagsonpal Pharmaceuticals to acquire Wellness Portfolio of Group Pharmaceuticals
- Acquisition / mergerJagsonpal Pharmaceuticals to acquire Wellness Portfolio of Group Pharmaceuticals
Other acquisition / merger filings this fortnight
- Acquisition / mergerSahana Systems LtdSahana Defence Limited to acquire 60% stake in Siddhanta Machining Pvt Ltd
- Acquisition / mergerSahana Systems LtdSahana Defence Limited to acquire 60% stake in Siddhanta Machining Pvt Ltd
- Acquisition / mergerIndo Borax & Ch.Indo Borax acquires 64.26% stake in Kronox Lab Sciences and appoints new MD & CEO
- Acquisition / mergerSh.Pushkar Chem.Shree Pushkar Chemicals & Fertilisers Ltd: Withdrawal of Merger Scheme by NCLT
- Acquisition / mergerEFC (I)EFC (I) Limited completes acquisition of 100% stake in Ultrafresh Modular Solutions Ltd.
- Acquisition / mergerSunteck Realty LtdSunteck Realty approves scheme with Satguru and appoints EY as Internal Auditor
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.